Shots:
The US FDA has approved the Sonnet 3 audio processor for MED-EL cochlear implants; commercially available in early 2025. Also, Pts implanted with MED-EL as of Sep 1, 2024, can access one-time exchange for Sonnet 3 in the TechSwap Program
Sonnet 3 is 2g lighter & ~18% shorter than Sonnet 2 with features…
